Proteomic approaches and identification of novel therapeutic targets for alcoholism

Neuropsychopharmacology

Volumn 39, Issue 1, 2014, Pages 104-130

  Gorini, Giorgio ^a   Adron Harris, R ^a   Dayne Mayfield, R ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

addiction; dependence; gene expression; miRNA; protein expression; proteinprotein interactions

Indexed keywords

ALCOHOL; BRAIN PROTEIN; CALMODULIN; CLUSTERIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; ION CHANNEL; MICRORNA; NEUROGRANIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEOME; BIOLOGICAL MARKER;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; BRAIN FUNCTION; BRAIN REGION; CELL CULTURE; DRINKING BEHAVIOR; GENE CONTROL; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL PROTEOMICS; SYSTEMS BIOLOGY; UPREGULATION; ZEBRA FISH; ANIMAL; BRAIN; DRUG DEVELOPMENT; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES; PROTEOMICS;

ALCOHOLISM; ANIMALS; BIOLOGICAL MARKERS; BRAIN; DRUG DISCOVERY; GENE EXPRESSION REGULATION; HUMANS; ION CHANNELS; MOLECULAR TARGETED THERAPY; PROTEOMICS; SYSTEMS BIOLOGY;

EID: 84890474728     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.182     Document Type: Review

References (270)

1. Abul-Husn NS, Bushlin I, Moró n JA, Jenkins SL, Dolios G, Wang R et al. (2009). Systems approach to explore components and interactions in the presynapse. Proteomics 9: 3303-3315
2. Abul-Husn NS, Devi LA (2006). Neuroproteomics of the synapse and drug addiction. J Pharmacol Exp Ther 318: 461-468
3. Addolorato G, Leggio L, Hopf FW, Diana M, Bonci A (2012). Novel therapeutic strategies for alcohol and drug addiction: Focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology 37: 163-177
4. Aderem A (2005). Systems biology: Its practice and challenges. Cell 121: 511-513
5. Aertgeerts B, Buntinx F, Ansoms S, Fevery J (2001). Screening properties of questionnaires and laboratory tests for the detection of alcohol abuse or dependence in a general practice population. Br J Gen Pract 51: 206-217
6. Alexander-Kaufman K, Cordwell S, Harper C, Matsumoto I (2007a). A proteome analysis of the dorsolateral prefrontal cortex in human alcoholic patients. Proteomics Clin Appl 1: 62-72
7. Alexander-Kaufman K, Harper C, Wilce P, Matsumoto I (2007b). Cerebellar vermis proteome of chronic alcoholic individuals. Alcohol Clin Exp Res 31: 1286-1296
8. Alexander-Kaufman K, James G, Sheedy D, Harper C, Matsumoto I (2006). Differential protein expression in the prefrontal white matter of human alcoholics: A proteomics study. Mol Psychiatry 11: 56-65
9. Alte D, Luedemann J, Rose HJ, John U (2004). Laboratory markers carbohydratedeficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: Results from the Study of Health in Pomerania (SHIP). Alcohol Clin Exp Res 28: 931-940
10. Altelaar AFM, Munoz J, Heck AJR (2013). Next-generation proteomics: Towards an integrative view of proteome dynamics. Nat Rev Genet 14: 35-48
11. Anni H, Israel Y (2002). Proteomics in alcohol research. Alcohol Res Health 26: 219-232
12. Anton RF (2010). Editorial commentary: Alcohol biomarker papers. Alcohol Clin Exp Res 34: 939-940
13. Anton RF, Lieber C, Tabakoff B (2002). Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: Results from a multisite study. Alcohol Clin Exp Res 26: 1215-1222
14. Anton RF, Moak DH (1994). Carbohydrate-deficient transferrin and gammaglutamyltransferase as markers of heavy alcohol consumption: Gender differences. Alcohol Clin Exp Res 18: 747-754
15. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA 295: 2003-2017
16. Arkin MR, Wells JA (2004). Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream. Nat Rev Drug Discov 3: 301-317
17. Auffray C, Imbeaud S, Roux-Rouquié M, Hood L (2003). From functional genomics to systems biology: Concepts and practices. C R Biol 326: 879-892
18. Baek D, Villé n J, Shin C, Camargo FD, Gygi SP, Bartel DP (2008). The impact of microRNAs on protein output. Nature 455: 64-71
19. Bailey RC (2009). New multiparameter bioanalytical technologies for applications in personalized medicine, drug discovery, and fundamental biology. Bioanalysis 1: 1043-1047
20. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B (2007). Quantitative mass spectrometry in proteomics: A critical review. Anal Bioanal Chem 389: 1017-1031
21. Barth J, Volknandt W (2011). Proteomic investigations of the synaptic vesicle interactome. Expert Rev Proteomics 8: 211-220
22. Bearer CF, Bailey SM, Hoek JB (2010). Advancing alcohol biomarkers research. Alcohol Clin Exp Res 34: 941-945
23. Beck O, Stephanson N, Bottcher M, Dahmen N, Fehr C, Helander A (2007). Biomarkers to disclose recent intake of alcohol: Potential of 5-hydroxytryptophol glucuronide testing using new direct UPLC-Tandem MS and ELISA methods. Alcohol Alcohol 42: 321-325
24. Bell RL, Kimpel MW, Rodd ZA, Strother WN, Bai F, Peper CL et al. (2006). Protein expression changes in the nucleus accumbens and amygdala of inbred alcoholpreferring rats given either continuous or scheduled access to ethanol. Alcohol 40: 3-17
25. Bell RL, Sable HJK, Colombo G, Hyytia P, Rodd ZA, Lumeng L (2012). Animal models for medications development targeting alcohol abuse using selectively bred rat lines: Neurobiological and pharmacological validity. Pharmacol Biochem Behav 103: 119-155
26. Bendroth P, Kronstrand R, Helander A, Greby J, Stephanson N, Krantz P (2008). Comparison of ethyl glucuronide in hair with phosphatidylethanol in whole blood as post-mortem markers of alcohol abuse. Forensic Sci Int 176: 76-81
27. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Socy Ser B 57: 289-300
28. Ben-Shahar O, Sacramento AD, Miller BW, Webb SM, Wroten MG, Silva HE et al. (2013). Deficits in ventromedial prefrontal cortex group 1 metabotropic glutamate receptor function mediate resistance to extinction during protracted withdrawal from an extensive history of cocaine self-Administration. J Neurosci 33: 495-506a.
29. Bhardwaj N, Lu H (2005). Correlation between gene expression profiles and protein-protein interactions within and across genomes. Bioinformatics 21: 2730-2738
30. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W (2006). Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125: 1111-1124
31. Bhave SV, Hornbaker C, Phang TL, Saba L, Lapadat R, Kechris K et al. (2007). The PhenoGen informatics website: Tools for analyses of complex traits. BMC Genet 8: 59
32. Bierczynska-Krzysik A, Bonar E, Drabik A, Noga M, Suder P, Dylag T et al. (2006). Rat brain proteome in morphine dependence. Neurochem Int 49: 401-406
33. Blednov YA, Borghese CM, McCracken ML, Benavidez JM, Geil CR, Osterndorff-Kahanek E et al. (2011). Loss of ethanol conditioned taste aversion and motor stimulation in knockin mice with ethanol-insensitive a2-containing GABA(A) receptors. J Pharmacol Exp Ther 336: 145-154
34. Borghese CM, Harris RA (2012). Alcohol dependence and genes encoding a2 and g1 GABAA receptor subunits: Insights from humans and mice. Alcohol Res 34: 345-353
35. Borghese CM, Henderson LA, Bleck V, Trudell JR, Harris RA (2003). Sites of excitatory and inhibitory actions of alcohols on neuronal alpha2beta4 nicotinic acetylcholine receptors. J Pharmacol Exp Ther 307: 42-52
36. Borucki K, Dierkes J, Wartberg J, Westphal S, Genz A, Luley C (2007). In heavy drinkers, fatty acid ethyl esters remain elevated for up to 99 h. Alcohol Clin Exp Res 31: 423-427
37. Boukli NM, Saiyed ZM, Ricaurte M, Rodriguez JW, Ríos Olivares E, Cubano LA et al. (2010). Implications of ER stress, the unfolded protein response, and pro-And anti-Apoptotic protein fingerprints in human monocyte-derived dendritic cells treated with alcohol. Alcohol Clin Exp Res 34: 2081-2088
38. Brodin L, Low P, Shupliakov O (2000). Sequential steps in clathrin-mediated synaptic vesicle endocytosis. Curr Opin Neurobiol 10: 312-320
39. Bull JH, Ellison G, Patel A, Muir G, Walker M, Underwood M et al. (2001). Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br J Cancer 84: 1512-1519
40. Chen G, Gharib TG, Huang C-C, Taylor JMG, Misek DE, Kardia SLR et al. (2002). Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1: 304-313
41. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HYK, Chen R et al. (2012a). Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148: 1293-1307
42. Chen Z-W, Fuchs K, Sieghart W, Townsend RR, Evers AS (2012b). Deep amino acid sequencing of native brain GABAA receptors using high-resolution mass spectrometry. Mol Cell Proteomics 11: M111. 011445
43. Cheng MH, Coalson RD, Cascio M (2008). Molecular dynamics simulations of ethanol binding to the transmembrane domain of the glycine receptor: Implications for the channel potentiation mechanism. Proteins 71: 972-981
44. Chung C, Emili A, Frey BJ (2013). Non-parametric Bayesian approach to posttranslational modification refinement of predictions from tandem mass spectrometry. Bioinformatics 29: 821-829
45. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002). CDT, GGT, and AST as markers of alcohol use: The WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26: 332-339
46. Coombs KM (2011). Quantitative proteomics of complex mixtures. Expert Rev Proteomics 8: 659-677
47. Crabbe JC, Phillips TJ, Belknap JK (2010). The complexity of alcohol drinking: Studies in rodent genetic models. Behav Genet 40: 737-750
48. Damodaran S, Dlugos CA, Wood TD, Rabin RA (2006). Effects of chronic ethanol administration on brain protein levels: A proteomic investigation using 2-D DIGE system. Eur J Pharmacol 547: 75-82
49. Davis MA, Hanash S (2006). High-Throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy. Breast Cancer Res 8: 217
50. Dayon L, Hainard A, Licker V, Turck N, Kuhn K, Hochstrasser DF et al. (2008). Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Anal Chem 80: 2921-2931
51. Deken SL, Beckman ML, Boos L, Quick MW (2000). Transport rates of GABA transporters: Regulation by the N-Terminal domain and syntaxin 1A. Nat Neurosci 3: 998-1003
52. Dev KK (2004). Making protein interactions druggable: Targeting PDZ domains. Nat Rev Drug Discov 3: 1047-1056
53. Dlugos CA, Rabin RA (2003). Ethanol effects on three strains of zebrafish: Model system for genetic investigations. Pharmacol Biochem Behav 74: 471-480
54. Dodd PR, Lewohl JM (1998). Cell death mediated by amino acid transmitter receptors in human alcoholic brain damage: Conflicts in the evidence. Ann N Y Acad Sci 844: 50-58
55. Drabik A, Bierczynska-Krzysik A, Bodzon-Kulakowska A, Suder P, Kotlinska J, Silberring J (2007). Proteomics in neurosciences. Mass Spectrom Rev 26: 432-450
56. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F et al. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74
57. Engholm-Keller K, Larsen MR (2013). Technologies and challenges in large-scale phosphoproteomics. Proteomics 13: 910-931
58. Etheridge N, Lewohl JM, Mayfield RD, Harris RA, Dodd PR (2009). Synaptic proteome changes in the superior frontal gyrus and occipital cortex of the alcoholic brain. Proteomics Clin Appl 3: 730-742
59. Etheridge N, Mayfield RD, Harris RA, Dodd PR (2011). Identifying changes in the synaptic proteome of cirrhotic alcoholic superior frontal gyrus. Curr Neuropharmacol 9: 122-128
60. Fei SS, Wilmarth PA, Hitzemann RJ, McWeeney SK, Belknap JK, David LL (2011). Protein database and quantitative analysis considerations when integrating genetics and proteomics to compare mouse strains. J Proteome Res 10: 2905-2912
61. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-Transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 9: 102-114
62. Foroud T, Phillips TJ (2012). Assessing the genetic risk for alcohol use disorders. Alcohol Res 34: 266-272
63. Freeman WM, Salzberg AC, Gonzales SW, Grant KA, Vrana KE (2010). Classification of alcohol abuse by plasma protein biomarkers. Biol Psychiatry 68: 219-222
64. Freeman WM, Vrana KE (2010). Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders. Alcohol Clin Exp Res 34: 946-954
65. Garbutt JC (2009). The state of pharmacotherapy for the treatment of alcohol dependence. J Subst Abuse Treat 36: S15-S23
66. Garner CC, Nash J, Huganir RL (2000). PDZ domains in synapse assembly and signalling. Trends Cell Biol 10: 274-280
67. Geschwind DH (2003). DNA microarrays: Translation of the genome from laboratory to clinic. Lancet Neurol 2: 275-282
68. Gipson CD, Reissner KJ, Kupchik YM, Smith ACW, Stankeviciute N, Hensley-Simon ME et al. (2013). Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc Natl Acad Sci USA 110: 9124-9129
69. Godefroy O, Rousseaux M (1997). Novel decision making in patients with prefrontal or posterior brain damage. Neurology 49: 695-701
70. Gorini G, Bell RL, Mayfield RD (2011). Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening. Progr Mol Biol Transl Sci 98: 293-347
71. Gorini G, Roberts AJ, Mayfield RD (2013a). Neurobiological signatures of alcohol dependence revealed by protein profiling. Manuscript under review
72. Gorini G, Nunez YO, Mayfield RD (2013b). Integration of miRNA and protein profiling reveals coordinated neuroadaptations in the alcohol-dependent mouse brain. Manuscript under review
73. Gorini G, Ponomareva O, Shores KS, Person MD, Harris RA, Mayfield RD (2010). Dynamin-1 co-Associates with native mouse brain BKCa channels: Proteomics analysis of synaptic protein complexes. FEBS Lett 584: 845-851
74. Greenbaum D, Colangelo C, Williams K, Gerstein M (2003). Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4: 117
75. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L et al. (2002). Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 1: 323-333
76. Grosshans H, Filipowicz W (2008). Proteomics joins the search for microRNA targets. Cell 134: 560-562
77. Gunzerath L, Hewitt BG, Li T-K, Warren KR (2011). Alcohol research: Past, present, and future. Ann N Y Acad Sci 1216: 1-23
78. Guo A-Y, Sun J, Jia P, Zhao Z (2010a). Network analysis of EtOH-related candidate genes. Chem Biodivers 7: 1142-1152
79. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010b). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840
80. Guo QM, Zakhari S (2008). Commentary: Systems biology and its relevance to alcohol research. Alcohol Res Health 31: 5-11
81. Gygi SP, Rochon Y, Franza BR, Aebersold R (1999). Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19: 1720-1730
82. Han S, Gelernter J, Kranzler HR, Yang B-Z (2012). Ordered subset linkage analysis based on admixture proportion identifies new linkage evidence for alcohol dependence in African-Americans. Hum Genet 132: 397-403
83. Hargreaves GA, Quinn H, Kashem MA, Matsumoto I, McGregor IS (2009). Proteomic analysis demonstrates adolescent vulnerability to lasting hippocampal changes following chronic alcohol consumption. Alcohol Clin Exp Res 33: 86-94
84. Harper C (2009). The neuropathology of alcohol-related brain damage. Alcohol Alcohol 44: 136-140
85. Harris RA, Trudell JR, Mihic SJ (2008). Ethanol's molecular targets. Sci Signal 1: Re7
86. Hartwell LH, Hopfield JJ, Leibler S, Murray AW (1999). From molecular to modular cell biology. Nature 402: C47-C52
87. Heilig M, Egli M (2006). Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms. Pharmacol Ther 111: 855-876
88. Hemby SE (2010). Cocainomics: New insights into the molecular basis of cocaine addiction. J Neuroimmune Pharmacol 5: 70-82
89. Hemby SE, Tannu N (2009). Modeling substance abuse for applications in proteomics. Methods Mol Biol 566: 69-83
90. Hendrickson DG, Hogan DJ, McCullough HL, Myers JW, Herschlag D, Ferrell JE et al. (2009). Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol 7: E1000238
91. Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE (2005). Comprehensive label-free method for the relative quantification of proteins from biological samples. J Proteome Res 4: 1442-1450
92. Hock B, Schwarz M, Domke I, Grunert VP, Wuertemberger M, Schiemann U et al. (2005). Validity of carbohydrate-deficient transferrin (%CDT), g-glutamyltransferase (g-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: A study in patients with alcohol dependence and liver disorders of non-Alcoholic and alcoholic origin. Addiction 100: 1477-1486
93. Hoiseth G, Bernard JP, Karinen R, Johnsen L, Helander A, Christophersen AS et al. (2007). A pharmacokinetic study of ethyl glucuronide in blood and urine: Applications to forensic toxicology. Forensic Sci Int 172: 119-124
94. Hong-Brown LQ, Brown CR, Kazi AA, Huber DS, Pruznak AM, Lang CH (2010). Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction. J Cell Biochem 109: 1172-1184
95. Hood L, Heath JR, Phelps ME, Lin B (2004). Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643
96. Howard RJ, Murail S, Ondricek KE, Corringer P-J, Lindahl E, Trudell JR et al. (2011). Structural basis for alcohol modulation of a pentameric ligand-gated ion channel. Proc Natl Acad Sci USA 108: 12149-12154
97. Huang T-C, Pinto SM, Pandey A (2013). Proteomics for understanding miRNA biology. Proteomics 13: 558-567
98. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG (2000). Proteomic analysis of NMDA receptor-Adhesion protein signaling complexes. Nat Neurosci 3: 661-669
99. Hyman SE, Malenka RC, Nestler EJ (2006). Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598
100. Ittiwut C, Yang B-Z, Kranzler HR, Anton RF, Hirunsatit R, Weiss RD et al. (2012). GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. Alcohol Clin Exp Res 36: 588-593
101. Javors MA, Johnson BA (2003). Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption. Addiction 98(Suppl 2): 45-50
102. Jensen ON (2000). Modification-specific proteomics: Systematic strategies for analysing post-Translationally modified proteins. Trends Biotechnol 18(Suppl 1): 36-42
103. Jensen ON (2004). Modification-specific proteomics: Characterization of posttranslational modifications by mass spectrometry. Curr Opin Chem Biol 8: 33-41
104. Jupp B, Lawrence AJ (2010). New horizons for therapeutics in drug and alcohol abuse. Pharmacol Ther 125: 138-168
105. Kashem MA, Ahmed S, Sarker R, Ahmed EU, Hargreaves GA, McGregor IS (2012). Long-Term daily access to alcohol alters dopamine-related synthesis and signaling proteins in the rat striatum. Neurochem Int 61: 1280-1288
106. Kashem MA, Etages HD, Kopitar-Jerala N, McGregor IS, Matsumoto I (2009). Differential protein expression in the corpus callosum (body) of human alcoholic brain. J Neurochem 110: 486-495
107. Kashem MA, Harper C, Matsumoto I (2008). Differential protein expression in the corpus callosum (genu) of human alcoholics. Neurochem Int 53: 1-11
108. Kashem MA, James G, Harper C, Wilce P, Matsumoto I (2007). Differential protein expression in the corpus callosum (splenium) of human alcoholics: A proteomics study. Neurochem Int 50: 450-459
109. Kasinathan C, Vrana K, Beretta L, Thomas P, Gooch R, Worst T et al. (2004). The future of proteomics in the study of alcoholism. Alcohol Clin Exp Res 28: 228-232
110. Kaur P, Chance MR (2012). The utility of mass spectrometry based structural proteomics in biopharmaceutical biologics development. Integr Proteomics 442. Available at: Http://www.intechopen.com/books/integrative- proteomics/theutility-of-mass-spectrometry-based-structural-proteomics-in- biopharmaceutical-biologics-developm
111. Kemming D, Vogt U, Tidow N, Schlotter CM, Bürger H, Helms MWet al. (2006). Whole genome expression analysis for biologic rational pathway modeling: Application in cancer prognosis and therapy prediction. Mol Diagn Ther 10: 271-280
112. Khanna R, Zougman A, Stanley EF (2007). A proteomic screen for presynaptic terminal N-Type calcium channel (CaV2.2) binding partners. J Biochem Mol Biol 40: 302-314
113. Kim N, Han JY, Roh GS, Kim HJ, Kang SS, Cho GJ et al. (2012). Nuclear clusterin is associated with neuronal apoptosis in the developing rat brain upon ethanol exposure. Alcohol Clin Exp Res 36: 72-82
114. Kim YJ, Doyle ML (2010). Structural mass spectrometry in protein therapeutics discovery. Anal Chem 82: 7083-7089
115. Kirschner MW (2005). The meaning of systems biology. Cell 121: 503-504
116. Kissack JC, Bishop J, Roper AL (2008). Ethylglucuronide as a biomarker for ethanol detection. Pharmacotherapy 28: 769-781
117. Klemmer P, Smit AB, Li KW (2009). Proteomics analysis of immuno-precipitated synaptic protein complexes. J Proteomics 72: 82-90
118. Koch H, Meerkerk GJ, Zaat JO, Ham MF, Scholten RJ, Assendelft WJ (2004). Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: A systematic review. Alcohol Alcohol 39: 75-85
119. Konkimalla VB, Suhas VL, Chandra NR, Gebhart E, Efferth T (2007). Diagnosis and therapy of oral squamous cell carcinoma. Expert Rev Anticancer Ther 7: 317-329
120. Koob GF (2006). The neurobiology of addiction: A neuroadaptational view relevant for diagnosis. Addiction 101(Suppl 1): 23-30
121. Koob GF, Le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129
122. Kril JJ, Harper CG (1989). Neuronal counts from four cortical regions of alcoholic brains. Acta Neuropathol 79: 200-204
123. Langfelder P, Horvath S (2008). WGCNA: An R package for weighted correlation network analysis. BMC Bioinform 9: 559
124. Le MTN, Xie H, Zhou B, Chia PH, Rizk P, Um M et al. (2009). MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol Cell Biol 29: 5290-5305
125. Lea P, Ling M (2008). New molecular assays for cancer diagnosis and targeted therapy. Curr Opin Mol Ther 10: 251-259
126. Lee HT, Kim SK, Choi MR, Park JH, Jung KH, Chai YG (2013). Effects of the activated mitogen-Activated protein kinase pathway via the c-ros receptor tyrosine kinase on the T47D breast cancer cell line following alcohol exposure. Oncol Rep 29: 868-874
127. Leggio L, Addolorato G (2010). Pharmacotherapy of alcohol dependence: Past, present and future research. Curr Pharm Des 16: 2074-2075
128. Leite JF, Amoscato AA, Cascio M (2000). Coupled proteolytic and mass spectrometry studies indicate a novel topology for the glycine receptor. J Biol Chem 275: 13683-13689
129. Leite JF, Cascio M (2001). Structure of ligand-gated ion channels: Critical assessment of biochemical data supports novel topology. Mol Cell Neurosci 17: 777-792
130. Leung AKL, Young AG, Bhutkar A, Zheng GX, Bosson AD, Nielsen CB et al. (2011). Genome-wide identification of Ago2 binding sites from mouse embryonic stem cells with and without mature microRNAs. Nat Struct Mol Biol 18: 237-244
131. Lewohl JM, Dyk DD, Van, Craft GE, Innes DJ, Mayfield RD, Cobon G et al. (2004). The application of proteomics to the human alcoholic brain. Ann N Y Acad Sci 1025: 14-26
132. Lewohl JM, Nunez YO, Dodd PR, Tiwari GR, Harris RA, Mayfield RD (2011). Upregulation of microRNAs in brain of human alcoholics. Alcohol Clin Exp Res 35: 1928-1937
133. Li C, Xiong Q, Zhang J, Ge F, Bi L-J (2012). Quantitative proteomic strategies for the identification of microRNA targets. Expert Rev Proteomics 9: 549-559
134. Li KW, Klemmer P, Smit AB (2010). Interaction proteomics of synapse protein complexes. Anal Bioanal Chem 397: 3195-3202
135. Li MD, Wang J (2007). Neuroproteomics and its applications in research on nicotine and other drugs of abuse. Proteomics Clin Appl 1: 1406-1427
136. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH et al. (1999). Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282: 1061-1066
137. Litten RZ, Bradley AM, Moss HB (2010). Alcohol biomarkers in applied settings: Recent advances and future research opportunities. Alcohol Clin Exp Res 34: 955-967
138. Liu ET (2005). Systems biology, integrative biology, predictive biology. Cell 121: 505-506
139. Liu J, Lewohl JM, Harris RA, Dodd PR, Mayfield RD (2007). Altered gene expression profiles in the frontal cortex of cirrhotic alcoholics. Alcohol Clin Exp Res 31: 1460-1466
140. Liu J, Lewohl JM, Harris RA, Iyer VR, Dodd PR, Randall PK et al. (2006). Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals. Neuropsychopharmacology 31: 1574-1582
141. Lopez MF, Becker HC (2005). Effect of pattern and number of chronic ethanol exposures on subsequent voluntary ethanol intake in C57BL/6J mice. Psychopharmacology 181: 688-696
142. Lovinger DM (2006). Mixing proteomics and alcohol. Alcohol 40: 1-2
143. Lu J, Helton TD, Blanpied TA, Rá cz B, Newpher TM, Weinberg RJ et al. (2007). Postsynaptic positioning of endocytic zones and AMPA receptor cycling by physical coupling of dynamin-3 to Homer. Neuron 55: 874-889
144. Lu LJ, Xia Y, Paccanaro A, Yu H, Gerstein M (2005). Assessing the limits of genomic data integration for predicting protein networks. Genome Res 15: 945-953
145. Lull ME, Freeman WM, VanGuilder HD, Vrana KE (2010). The use of neuroproteomics in drug abuse research. Drug Alcohol Depend 107: 11-22
146. Maiya R, Ponomarev I, Linse KD, Harris RA, Mayfield RD (2007). Defining the dopamine transporter proteome by convergent biochemical and in silico analyses. Genes Brain Behav 6: 97-106
147. Maldonado-Devincci AM, Stevens SM Jr, Kirstein CL (2012). Investigation of agespecific behavioral and proteomic changes in an animal model of chronic ethanol exposure. Methods Mol Biol 829: 471-485
148. Mane SP, Evans C, Cooper KL, Crasta OR, Folkerts O, Hutchison SK et al. (2009). Transcriptome sequencing of the Microarray Quality Control (MAQC) RNA reference samples using next generation sequencing. BMC Genomics 10: 264
149. Mann M (2009). Comparative analysis to guide quality improvements in proteomics. Nat Methods 6: 717-719
150. Marcilla M, Albar JP (2013). Quantitative proteomics: A strategic ally to map protein interaction networks. IUBMB Life 65: 9-16
151. Marcotte ER, Srivastava LK, Quirion R (2003). cDNA microarray and proteomic approaches in the study of brain diseases: Focus on schizophrenia and Alzheimer's disease. Pharmacol Ther 100: 63-74
152. Martin-Fardon R, Weiss F (2013). Modeling relapse in animals. Curr Top Behav Neurosci 13: 403-432
153. Matsuda-Matsumoto H, Iwazaki T, Kashem MA, Harper C, Matsumoto I (2007). Differential protein expression profiles in the hippocampus of human alcoholics. Neurochem Int 51: 370-376
154. Matsumoto I (2009). Proteomics approach in the study of the pathophysiology of alcohol-related brain damage. Alcohol Alcohol 44: 171-176
155. Mayfield RD, Harris RA (2009). Gene expression profiling in blood: New diagnostics in alcoholism and addictioñNeuropsychopharmacology 34: 250-251
156. Mayfield RD, Harris RA, Schuckit MA (2008). Genetic factors influencing alcohol dependence. Br J Pharmacol 154: 275-287
157. McBride WJ, Schultz JA, Kimpel MW, McClintick JN, Wang M, You J et al. (2009). Differential effects of ethanol in the nucleus accumbens shell of alcohol-preferring (P), alcohol-non-preferring (NP) and Wistar rats: A proteomics study. Pharmacol Biochem Behav 92: 304-313
158. McCracken LM, Blednov YA, Trudell JR, Benavidez JM, Betz H, Harris RA (2013). Mutation of a zinc-binding residue in the glycine receptor a1 subunit changes ethanol sensitivity in vitro and alcohol consumption in vivo. J Pharmacol Exp Ther 344: 489-500
159. McCracken ML, Borghese CM, Trudell JR, Harris RA (2010). A transmembrane amino acid in the GABAA receptor b2 subunit critical for the actions of alcohols and anesthetics. J Pharmacol Exp Ther 335: 600-606
160. Miranda RC, Pietrzykowski AZ, Tang Y, Sathyan P, Mayfield D, Keshavarzian A et al. (2010). MicroRNAs: Master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res 34: 575-587
161. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P (2000). Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: 53-67
162. Montalto NJ, Bean P (2003). Use of contemporary biomarkers in the detection of chronic alcohol use. Med Sci Monit 9: RA285-RA290
163. Moreira S, Breton S, Burger G (2012). Unscrambling genetic information at the RNA level. Wiley Interdiscip Rev RNA 3: 213-228
164. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008). Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628
165. Mulligan MK, Ponomarev I, Hitzemann RJ, Belknap JK, Tabakoff B, Harris RA et al. (2006). Toward understanding the genetics of alcohol drinking through transcriptome meta-Analysis. Proc Natl Acad Sci USA 103: 6368-6373
166. Mulligan MK, Rhodes JS, Crabbe JC, Mayfield RD, Adron Harris R, Ponomarev I (2011). Molecular profiles of drinking alcohol to intoxication in C57BL/6J mice. Alcohol Clin Exp Res 35: 659-670
167. Murail S, Howard RJ, Broemstrup T, Bertaccini EJ, Harris RA, Trudell JR et al. (2012). Molecular mechanism for the dual alcohol modulation of Cys-loop receptors. PLoS Comput Biol 8: E1002710
168. Muth TR, Ahn J, Caplan MJ (1998). Identification of sorting determinants in the C-Terminal cytoplasmic tails of the gamma-Aminobutyric acid transporters GAT-2 and GAT-3. J Biol Chem 273: 25616-25627
169. Nam HW, Lee MR, Zhu Y, Wu J, Hinton DJ, Choi S et al. (2011). Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-Daspartate receptor signaling. Biol Psychiatry 69: 1043-1051
170. Nestler EJ (2000). Genes and addiction. Nat Genet 26: 277-281
171. Nestler EJ (2005). Is there a common molecular pathway for addictioñNat Neurosci 8: 1445-1449
172. Neuhold LA, Guo QM, Alper J, Velazquez JM (2004). High-Throughput proteomics for alcohol research. Alcohol Clin Exp Res 28: 203-210
173. Neumann T, Spies C (2003). Use of biomarkers for alcohol use disorders in clinical practice. Addiction 98(Suppl 2): 81-91
174. Nunez YO, Mayfield RD (2012). Understanding alcoholism through microRNA signatures in brains of human alcoholics. Frontiers in genetics 3: 43
175. Nutt DJ, King LA, Phillips LD (2010). Drug harms in the UK: A multicriteria decision analysis. Lancet 376: 1558-1565
176. Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2009). Clusterin: A forgotten player in Alzheimer's disease. Brain Res Rev 61: 89-104
177. Okutsu J, Tsunoda T, Kaneta Y, Katagiri T, Kitahara O, Zembutsu H et al. (2002). Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis. Mol Cancer Ther 1: 1035-1042
178. Ong S-E, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A et al. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386
179. Padayatti PS, Wang L, Gupta S, Orban T, Sun W, Salom D et al. (2013). A hybrid structural approach to analyze ligand binding by the 5-HT4 receptor. Mol Cell Proteomics 12: 1259-1271
180. Papagiannakopoulos T, Kosik KS (2009). MicroRNA-124: Micromanager of neurogenesis. Cell Stem Cell 4: 375-376
181. Park B, Jeong S-K, Lee W-S, Seong JK, Paik Y-K (2004). A simple pattern classification method for alcohol-responsive proteins that are differentially expressed in mouse brain. Proteomics 4: 3369-3375
182. Patel VJ, Thalassinos K, Slade SE, Connolly JB, Crombie A, Murrell JC et al. (2009). A Comparison of Labeling and Label-Free Mass Spectrometry-Based Proteomics Approaches. J Proteome Res 8: 3752-3759
183. Pennisi E (2012). Genomics. ENCODE project writes eulogy for junk DNA. Science 337: 1161
184. Pfefferbaum A (2004). Alcoholism damages the brain, but does moderate alcohol use? Lancet Neurol 3: 143-144
185. Phillips TJ, Belknap JK (2002). Complex-Trait genetics: Emergence of multivariate strategies. Nat Rev Neurosci 3: 478-485
186. Pianta A, Liniger B, Baumgartner MR (2013). Ethyl glucuronide in scalp and non-head hair: An intra-individual comparison. Alcohol Alcohol 48: 295-302
187. Pietrzykowski AZ, Friesen RM, Martin GE, Puig SI, Nowak CL, Wynne PM et al. (2008). Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 59: 274-287
188. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E et
189. Pitel AL, Beaunieux H, Witkowski T, Vabret F, Guillery-Girard B, Quinette P et al. (2007). Genuine episodic memory deficits and executive dysfunctions in alcoholic subjects early in abstinence. Alcohol Clin Exp Res 31: 1169-1178
190. Plazas-Mayorca MD, Vrana KE (2011). Proteomic investigation of epigenetics in neuropsychiatric disorders: A missing link between genetics and behavior? J Proteome Res 10: 58-65
191. Ponomarev I, Wang S, Zhang L, Harris RA, Mayfield RD (2012). Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. J Neurosci 32: 1884-1897
192. Potenza MN, Sofuoglu M, Carroll KM, Rounsaville BJ (2011). Neuroscience of behavioral and pharmacological treatments for addictions. Neuron 69: 695-712
193. Pragst F, Yegles M (2008). Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: A promising way for retrospective detection of alcohol abuse during pregnancy? Ther Drug Monit 30: 255-263
194. Přikrylová Vranová H, Mareš J, Nevrlý M, Stejskal D, Zapletalová J, Hluš tík P et al. (2010). CSF markers of neurodegeneration in Parkinson's disease. J Neural Transm 117: 1177-1181
195. Procopio DO, Saba LM, Walter H, Lesch O, Skala K, Schlaff G et al. (2012). Genetic markers of comorbid depression and alcoholism in women. Alcohol Clin Exp Res 37: 896-904
196. Rahman S, Sahakian BJ, Hodges JR, Rogers RD, Robbins TW (1999). Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain 122(Part 8): 1469-1493
197. Ramani AK, Bunescu RC, Mooney RJ, Marcotte EM (2005). Consolidating the set of known human protein-protein interactions in preparation for large-scale mapping of the human interactome. Genome Biol 6: R40
198. Ratti MT, Bo P, Giardini A, Soragna D (2002). Chronic alcoholism and the frontal lobe: Which executive functions are imparied? Acta Neurol Scand 105: 276-281
199. Reilly MT, Cunningham KA, Natarajan A (2009). Protein-protein interactions as therapeutic targets in neuropsychopharmacology. Neuropsychopharmacology 34: 247-248
200. Reilly MT, Harris RA, Noronha A (2012). Using genetically engineered animal models in the postgenomic era to understand gene function in alcoholism. Alcohol Res 34: 282-291
201. Reker D, Malmström L (2012). Bioinformatic challenges in targeted proteomics. J Proteome Res 11: 4393-4402
202. Renthal W, Nestler EJ (2009). Chromatin regulation in drug addiction and depression. Dialogues Clin Neurosci 11: 257-268
203. Reynaud M, Schellenberg F, Loisequx-Meunier MN, Schwan R, Maradeix B, Planche F et al. (2000). Objective diagnosis of alcohol abuse: Compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV). Alcohol Clin Exp Res 24: 1414-1419
204. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D et al. (2004). Large-scale meta-Analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 101: 9309-9314
205. Roberts JA, Bottrill AR, Mistry S, Evans RJ (2012). Mass spectrometry analysis of human P2-1 receptors; insight into phosphorylation, modelling and conformational changes. J Neurochem 123: 725-735
206. Rodd ZA, Bertsch BA, Strother WN, Le-Niculescu H, Balaraman Y, Hayden E et al. (2007). Candidate genes, pathways and mechanisms for alcoholism: An expanded convergent functional genomics approach. Pharmacogenom J 7: 222-256
207. Rogowska-Wrzesinska A, Bihan M-C, Le, Thaysen-Andersen M, Roepstorff P (2013). 2D gels still have a niche in proteomics. J Proteomics 88: 4-13
208. Romanova EV, Lee JE, Kelleher NL, Sweedler JV, Gulley JM (2012). Comparative peptidomics analysis of neural adaptations in rats repeatedly exposed to amphetamine. J Neurochem 123: 276-287
209. Rosalki SB (2004). Carbohydrate-deficient transferrin: A marker of alcohol abuse. Int J Clin Pract 58: 391-393
210. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using aminereactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169
211. Saito M, Smiley J, Toth R, Vadasz C (2002). Microarray analysis of gene expression in rat hippocampus after chronic ethanol treatment. Neurochem Res 27: 1221-1229
212. Sakai JT, Mikulich-Gilbertson SK, Long RJ, Crowley TJ (2006). Validity of transdermal alcohol monitoring: Fixed and self-regulated dosing. Alcohol Clin Exp Res 30: 26-33
213. Sari Y, Zhang M, Mechref Y (2010). Differential expression of proteins in fetal brains of alcohol-Treated prenatally C57BL/6 mice: A proteomic investigation. Electrophoresis 31: 483-496
214. Sauguet L, Poitevin F, Murail S, Renterghem C, Van, Moraga-Cid G, Malherbe L et al. (2013). Structural basis for ion permeation mechanism in pentameric ligand-gated ion channels. EMBO J 32: 728-741
215. Schuckit MA (2009). An overview of genetic influences in alcoholism. J Subst Abuse Treat 36: S5-14
216. Schwan R, Albuisson E, Malet L, Loiseaux M-N, Reynaud M, Schellenberg F et al. (2004). The use of biological laboratory markers in the diagnosis of alcohol misuse: An evidence-based approach. Drug Alcohol Depend 74: 273-279
217. Schwanhä usser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J et al. (2011). Global quantification of mammalian gene expression control. Nature 473: 337-342
218. Serpa JJ, Parker CE, Petrotchenko EV, Han J, Pan J, Borchers CH (2012). Mass spectrometry-based structural proteomics. Eur J Mass Spectrom (Chichester, UK) 18: 251-267
219. Shen Q, Temple S (2009). Fine control: MicroRNA regulation of adult neurogenesis. Nat Neurosci 12: 369-370
220. Sherwood CA, Eastham A, Lee LW, Risler J, Mirzaei H, Falkner JA et al. (2009). Rapid optimization of MRM-MS instrument parameters by subtle alteration of precursor and product m/z targets. J Proteome Res 8: 3746-3751
221. Shi T, Su D, Liu T, Tang K, Camp DG II, Qian W-J et al. (2012). Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 12: 1074-1092
222. Sikela JM, Maclaren EJ, Kim Y, Karimpour-Fard A, Cai W-W, Pollack J et al. (2006). DNA microarray and proteomic strategies for understanding alcohol action. Alcohol Clin Exp Res 30: 700-708
223. Sircar R, Sircar D (2005). Adolescent rats exposed to repeated ethanol treatment show lingering behavioral impairments. Alcohol Clin Exp Res 29: 1402-1410
224. Smith AD, Weiss F (1999). Ethanol exposure differentially alters central monoamine neurotransmission in alcohol-preferring versus -nonpreferring rats. J Pharmacol Exp Ther 288: 1223-1228
225. Smith DI (2002). Transcriptional profiling develops molecular signatures for ovarian tumors. Cytometry 47: 60-62
226. Sobell LC, Agrawal S, Sobell MB (1999). Utility of liver function tests for screening 'alcohol abusers' who are not severely dependent on alcohol. Subst Use Misuse 34: 1723-1732
227. Song Z, Guo Q, Zhang J, Li M, Liu C, Zou W (2012). Proteomic analysis of PKCgrelated proteins in the spinal cord of morphine-Tolerant rats. PLoS One 7: E42068
228. Spanagel R (2005). How to measure relapse in animals. Drugs Rel Prev Alcohol 13-21
229. Spanagel R (2009). Alcoholism: A systems approach from molecular physiology to addictive behavior. Physiol Rev 89: 649-705
230. Staub O, Rotin D (1997). Regulation of ion transport by protein-protein interaction domains. Curr Opin Nephrol Hypertens 6: 447-454
231. Sullivan EV, Pfefferbaum A (2005). Neurocircuitry in alcoholism: A substrate of disruption and repair. Psychopharmacology (Berl) 180: 583-594
232. Sung U, Jennings JL, Link AJ, Blakely RD (2005). Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins. Biochem Biophys Res Commun 333: 671-678
233. Swift R (2003). Direct measurement of alcohol and its metabolites. Addiction 98(Suppl 2): 73-80
234. Swift R (2007). Emerging approaches to managing alcohol dependence. Am J Health Syst Pharm 64: S12-S22
235. Tabakoff B, Saba L, Printz M, Flodman P, Hodgkinson C, Goldman D et al. (2009). Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol 7: 70
236. Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N et al. (2009). mRNA-Seq whole-Transcriptome analysis of a single cell. Nat Methods 6: 377-382
237. Tapocik JD, Solomon M, Flanigan M, Meinhardt M, Barbier E, Schank JR et al. (2013). Coordinated dysregulation of mRNAs and microRNAs in the rat medial prefrontal cortex following a history of alcohol dependence. Pharmacogenom J 13: 286-296
238. Taxman DJ, MacKeigan JP, Clements C, Bergstralh DT, Ting JP (2003). Transcriptional profiling of targets for combination therapy of lung carcinoma with paclitaxel and mitogen-Activated protein/extracellular signal-regulated kinase kinase inhibitor. Cancer Res 63: 5095-5104
239. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al. (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362: 798-805
240. Torrente MP, Freeman WM, Vrana KE (2012). Protein biomarkers of alcohol abuse. Expert Rev Proteomics 9: 425-436
241. Treistman SN, Martin GE (2009). BK Channels: Mediators and models for alcohol tolerance. Trends Neurosci 32: 629-637
242. Trougakos IP, Lourda M, Antonelou MH, Kletsas D, Gorgoulis VG, Papassideri IS et al. (2009). Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-Activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin Cancer Res 15: 48-59
243. Uhlen M, Ponten F (2005). Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 4: 384-393
244. Vetulani J (2001). Drug addiction. Part II. Neurobiology of addiction. Pol J Pharmacol 53: 303-317
245. Vogel C, Marcotte EM (2012). Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13: 227-232
246. Vogel N, Kluck CJ, Melzer N, Schwarzinger S, Breitinger U, Seeber S et al. (2009). Mapping of disulfide bonds within the amino-Terminal extracellular domain of the inhibitory glycine receptor. J Biol Chem 284: 36128-36136
247. Volkow N, Li TK (2005). The neuroscience of addiction. Nat Neurosci 8: 1429-1430
248. Walter NAR, Bottomly D, Laderas T, Mooney MA, Darakjian P, Searles RP et al. (2009). High throughput sequencing in mice: A platform comparison identifies a preponderance of cryptic SNPs. BMC Genom 10: 379
249. Wang J, Yuan W, Li MD (2011). Genes and pathways co-Associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/ methamphetamine, cocaine, marijuana, morphine, and/or nicotine: A review of proteomics analyses. Mol Neurobiol 44: 269-286
250. Wepf A, Glatter T, Schmidt A, Aebersold R, Gstaiger M (2009). Quantitative interaction proteomics using mass spectrometry. Nat Methods 6: 203-205
251. Westerhoff HV, Palsson BO (2004). The evolution of molecular biology into systems biology. Nat Biotechnol 22: 1249-1252
252. Weston AD, Hood L (2004). Systems biology, proteomics, and the future of health care: Toward predictive, preventative, and personalized medicine. J Proteome Res 3: 179-196
253. White AM, Ghia AJ, Levin ED, Swartzwelder HS (2000). Binge pattern ethanol exposure in adolescent and adult rats: Differential impact on subsequent responsiveness to ethanol. Alcohol Clin Exp Res 24: 1251-1256
254. Witzmann FA, Li J, Strother WN, McBride WJ, Hunter L, Crabb DW et al. (2003). Innate differences in protein expression in the nucleus accumbens and hippocampus of inbred alcohol-preferring and -nonpreferring rats. Proteomics 3: 1335-1344
255. Witzmann FA, Strother WN (2004). Proteomics and alcoholism. Int Rev Neurobiol 61: 189-214
256. Wong CCY, Mill J, Fernandes C (2011). Drugs and addiction: An introduction to epigenetics. Addiction 106: 480-489
257. World Health Organization (2010): Global strategy to reduce the harmful use of alcohol. Available at: Http://www.who.int/substance-abuse/publications/ alcohol/ en/index.html
258. Worst TJ, Tan JC, Robertson DJ, Freeman WM, Hyytia P, Kiianmaa K et al. (2005). Transcriptome analysis of frontal cortex in alcohol-preferring and nonpreferring rats. J Neurosci Res 80: 529-538
259. Wu CC, MacCoss MJ, Howell KE, Matthews DE, Yates JR III (2004). Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem 76: 4951-4959
260. Wu CC, MacCoss MJ, Howell KE, Yates JR III (2003). A method for the comprehensive proteomic analysis of membrane proteins. Nat Biotechnol 21: 532-538
261. Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T et al. (2010). Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 30 untranslated region. Oncogene 29: 2302-2308
262. Wurst FM, Kelso E, Weinmann W, Pragst F, Yegles M, Sundstrom Poromaa I (2008a). Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT-A pilot study in a populationbased sample of Swedish women. Am J Obstet Gynecol 198: E1-e5
263. Wurst FM, Yegles M, Alling C, Aradottir S, Dierkes J, Wiesbeck GA et al. (2008b). Measurement of direct ethanol metabolites in a case of a former driving under the influence (DUI) of alcohol offender, now claiming abstinence. Int J Legal Med 122: 235-239
264. Xuei X, Flury-Wetherill L, Dick D, Goate A, Tischfield J, Nurnberger J Jr et al. (2010). GABRR1 and GABRR2, encoding the GABA-A receptor subunits rho1 and rho2, are associated with alcohol dependence. Am J Med Genet B 153B: 418-427
265. Young C, Klocke BJ, Tenkova T, Choi J, Labruyere J, Qin Y-Q et al. (2003). Ethanolinduced neuronal apoptosis in vivo requires BAX in the developing mouse brain. Cell Death Differ 10: 1148-1155
266. Zembutsu H, Ohnishi Y, Tsunoda T, Furukawa Y, Katagiri T, Ueyama Y et al. (2002). Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res 62: 518-527
267. Zhang B, Horvath S (2005). A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 4: Article17
268. Zhang QC, Petrey D, Deng L, Qiang L, Shi Y, Thu CA et al. (2012). Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature 490: 556-560
269. Zhao Y, Brasier AR (2013). Applications of selected reaction monitoring (SRM)-mass spectrometry (MS) for quantitative measurement of signaling pathways. Methods 61: 313-322
270. Zhu W, Smith JW, Huang C-M (2010). Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol 2010: 840518